Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

17 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Alzheimer's disease: a comprehensive review of epidemiology, risk factors, symptoms diagnosis, management, caregiving, advanced treatments and associated challenges.
Safiri S, Ghaffari Jolfayi A, Fazlollahi A, Morsali S, Sarkesh A, Daei Sorkhabi A, Golabi B, Aletaha R, Motlagh Asghari K, Hamidi S, Mousavi SE, Jamalkhani S, Karamzad N, Shamekh A, Mohammadinasab R, Sullman MJM, Şahin F, Kolahi AA. Safiri S, et al. Among authors: morsali s. Front Med (Lausanne). 2024 Dec 16;11:1474043. doi: 10.3389/fmed.2024.1474043. eCollection 2024. Front Med (Lausanne). 2024. PMID: 39736972 Free PMC article. Review.
Safety and Efficacy of Trospium Chloride and Solifenacin in Stroke-Induced Neurogenic Lower Urinary Tract Dysfunction: A Randomized Controlled Trial.
Hajebrahimi S, Pourmohammad A, Konstantinidis C, Samarinas M, Morsali S, Mostafaei H, Farhoudi M, Rahnama'i MS, Beheshti R, Salehi-Pourmehr H. Hajebrahimi S, et al. Among authors: morsali s. Neurourol Urodyn. 2025 Jan;44(1):85-95. doi: 10.1002/nau.25614. Epub 2024 Oct 29. Neurourol Urodyn. 2025. PMID: 39469916 Clinical Trial.
The effects of melatonin supplementation on neurobehavioral outcomes and clinical severity in rodent models of multiple sclerosis; a systematic review and meta-analysis.
Razmaray H, Nasiri E, Vakilipour P, Morsali S, Moradi A, Ebrahimian A, Rashidi S, Mosaddeghi-Heris R, Sadigh-Eteghad S, Naseri A. Razmaray H, et al. Among authors: morsali s. Inflammopharmacology. 2024 Apr;32(2):927-944. doi: 10.1007/s10787-023-01414-7. Epub 2024 Jan 22. Inflammopharmacology. 2024. PMID: 38252220 Review.
17 results